US Patent 11883495 Anti-CD47 antibodies and uses thereof
Patent 11883495 was granted and assigned to LePU Biopharma Co on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+291 characters)
US Patent 11883495 Anti-CD47 antibodies and uses thereof
Article
Patent abstract
Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Wenci Gong0
Yiwei Tou0
Date of Patent
January 30, 2024
0Patent Application Number
173161520
Date Filed
May 10, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11883495 Anti-CD47 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.